Serum CCL21 as a Potential Biomarker for Cognitive Impairment in Spinal Cord Injury

Table 1

Demographics and clinical characteristics.

	NC ()	SCI ()
Age (years)			0.445
Gender (male/female)	35/14	56/28	0.569
BMI (kg/m^2)			0.204
TG (mmol/L)			0.412
LDL-C (mmol/L)			0.218
FBG (mmol/L)			0.718
SBP (mmHg)			0.585
DBP (mmHg)			0.231
CCL21 (pg/ml)			<0.001
MoCA (points)			<0.001

NC: normal controls; SCI: spinal cord injury; BMI: body mass index; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; FBG: fasting plasma glucose; SBP: systolic blood pressure; DBP: diastolic blood pressure; CCL21: chemokine (C-C motif) ligand 21; MoCA: Montreal Cognitive Assessment.